温肾壮筋法治疗腰椎间盘突出症的临床研究
|
摘要
目的：观察中药内服治疗腰椎间盘突出症的临床疗效。
方法：随机将80例腰椎间盘突出症患者分成两组,即用温肾壮筋法指导中药内服治疗的治疗组和传统的腰椎牵引治疗的对照组(各40例)。均于4周后观察比较两组患者治疗前后临床症状与体征、疼痛程度、以及影像学的变化,进行疗效评定。治疗后3、6、9个月随访观察症状复发情况。
结果：(1)治疗组的治愈率、显效率和有效率分别为37.5%、72.5%和95%，而对照组分别为22.5%、50%和87.5%,经比较说明治疗组的总体临床疗效优于对照组(P<0.05),且治愈率与显效率均高于对照组(P<0.05)；而有效率比较则无明显差异(P>0.05)；治疗组在缓解症状与体征、疼痛方面疗效优于对照组(P<0.05)。(2)治疗后3个月两组的复发率分别为2.63%和11.43%,无显著性差异(P>0.05)；治疗后6、9个月两组的复发率分别为7.89%和25.71%、13.16%和40%,有显著性差异(P<0.05)。说明治疗组在防止复发、巩固疗效方面优于对照组。(3)腰椎CT片椎间盘突出征象改善情况方面,两组的改善率分别为34.37%和45.71%,两组治疗前、后分别比较无显著差异(P>0.05),两组间改善率比较也无显著性差异(P>0.05)。
结论：中药内服是治疗腰椎间盘突出症的一种疗效显著、复发率低、安全可靠的治疗方法。
Objective:To observe the clinical therapeutic effects of curing the lumbar disc herniation by Chinese herbal oral administration.
Methods:80 cases of lumbar disc herniation patients were divided stochastic into two groups:therapeutic group with 40 cases was treated with the Chinese herbal oral administration and the traditional group with 40 cases was treated with lumbar traction. After 4 weeks treatment, these patients'clinical symptom and physical sign, pain degrees, and image were compared with before and after treatment and each other to observe the therapeutic effects. Post-treatment 3,6,9 months, to observe the symptom recurrence condition after follow-up visit.
Results:(1) The cure rate, the marked effective rate and the defective rate were 37.5%,72.5% and 95% in therapeutic group, and they were 22.5%, 50% and 87.5% in control group. The total therapeutic effects, cure rate and marked effective rate of therapeutic group was significantly higher than control group (P<0.05). But there was no significant difference in the effective rate between them (P>0.05).The therapeutic effects of relieve symptom and physical sign of therapeutic group was significantly higher than control group (P<0.05). (2) Post-treatment 3 months, the recurrence rates of two groups were 2.63% and 11.43%, there was no significant difference between them (P>0.05). But post-treatment 6,9 months, the recurrence rates of two groups were 7.89% and 25.71%, 13.16% and 40%, there was significant difference between them (P<0.05). The result suggested that therapeutic group was more outweigh than control group in preventing the symptom recurrence and securing the therapeutic effects. (3) The improvement rates of two groups were 34.37% and 45.71% in lumbar CT herniation symptom. There was no significant difference between before and after treatment in two groups (P>0.05). There was also no significant difference between the improvement rates of two groups (P>0.05).
Conclusions:The Chinese herbal oral administration was a treatment which had marked therapeutic effects, low recurrence rate and safely to cure lumbar disc herniation.
方法：随机将80例腰椎间盘突出症患者分成两组,即用温肾壮筋法指导中药内服治疗的治疗组和传统的腰椎牵引治疗的对照组(各40例)。均于4周后观察比较两组患者治疗前后临床症状与体征、疼痛程度、以及影像学的变化,进行疗效评定。治疗后3、6、9个月随访观察症状复发情况。
结果：(1)治疗组的治愈率、显效率和有效率分别为37.5%、72.5%和95%，而对照组分别为22.5%、50%和87.5%,经比较说明治疗组的总体临床疗效优于对照组(P<0.05),且治愈率与显效率均高于对照组(P<0.05)；而有效率比较则无明显差异(P>0.05)；治疗组在缓解症状与体征、疼痛方面疗效优于对照组(P<0.05)。(2)治疗后3个月两组的复发率分别为2.63%和11.43%,无显著性差异(P>0.05)；治疗后6、9个月两组的复发率分别为7.89%和25.71%、13.16%和40%,有显著性差异(P<0.05)。说明治疗组在防止复发、巩固疗效方面优于对照组。(3)腰椎CT片椎间盘突出征象改善情况方面,两组的改善率分别为34.37%和45.71%,两组治疗前、后分别比较无显著差异(P>0.05),两组间改善率比较也无显著性差异(P>0.05)。
结论：中药内服是治疗腰椎间盘突出症的一种疗效显著、复发率低、安全可靠的治疗方法。
Objective:To observe the clinical therapeutic effects of curing the lumbar disc herniation by Chinese herbal oral administration.
Methods:80 cases of lumbar disc herniation patients were divided stochastic into two groups:therapeutic group with 40 cases was treated with the Chinese herbal oral administration and the traditional group with 40 cases was treated with lumbar traction. After 4 weeks treatment, these patients'clinical symptom and physical sign, pain degrees, and image were compared with before and after treatment and each other to observe the therapeutic effects. Post-treatment 3,6,9 months, to observe the symptom recurrence condition after follow-up visit.
Results:(1) The cure rate, the marked effective rate and the defective rate were 37.5%,72.5% and 95% in therapeutic group, and they were 22.5%, 50% and 87.5% in control group. The total therapeutic effects, cure rate and marked effective rate of therapeutic group was significantly higher than control group (P<0.05). But there was no significant difference in the effective rate between them (P>0.05).The therapeutic effects of relieve symptom and physical sign of therapeutic group was significantly higher than control group (P<0.05). (2) Post-treatment 3 months, the recurrence rates of two groups were 2.63% and 11.43%, there was no significant difference between them (P>0.05). But post-treatment 6,9 months, the recurrence rates of two groups were 7.89% and 25.71%, 13.16% and 40%, there was significant difference between them (P<0.05). The result suggested that therapeutic group was more outweigh than control group in preventing the symptom recurrence and securing the therapeutic effects. (3) The improvement rates of two groups were 34.37% and 45.71% in lumbar CT herniation symptom. There was no significant difference between before and after treatment in two groups (P>0.05). There was also no significant difference between the improvement rates of two groups (P>0.05).
Conclusions:The Chinese herbal oral administration was a treatment which had marked therapeutic effects, low recurrence rate and safely to cure lumbar disc herniation.
引文
[1]郑筱萸.中药新药临床研究指导原则(试行)[S].北京：中国医药科技出版社,2002：346-349
[2]国家中医药管理局.中医病证诊断疗效标准[M].南京：南京大学出版社,1994：193
[3]汪沪双.乌头碱抗风湿作用的药效学研究概述[J].基层中药杂志,1996,10(3)：45-46.
[4]董万超.肉桂的利用及药理作用[J]特种经济动植物,2005,6：43
[5]聂淑琴,梁爱华.鹿角胶新老剂型壮阳、补血作用的比较研究[J].中国中药杂志,1996,21(10)：625.
[6]王龙,张晓华.六种补胶的比较研究[J].中国中药杂志,1992,17(1)：19.
[7]吕晓东,张永祥,茹祥斌,山茱萸体液免疫抑制活性成分的药理学导向评价分离[J]解放军药学学报,2002,18(6)：357-359
[8]刘栋魏睦新：健脾补肾活血方延缓衰老的实验研究[J].河南中医,2000,20(4)：25-26
[9]徐增莱.淮山药多糖的免疫调节作用研究[J].时珍国医国药2007,18(5)：5-6
[10]Kim SS, Son YO, Chun JC, et al. Antioxidant property of an active component purified from the leaves of paraquat-tolerant Rehmannia glutinosa. Redox Rep,2005,10(6):311-318.
[11]赖娟华,徐丽瑛,饶华.等.杜仲叶化学成分和药理作用研究概况[J].实用中西医结合临床,2004,4(2)：67.
[12]王浴生.中药药理与应用[M].北京：人民卫生出版社,1983年,第1版
[13]余追,欧阳静萍,刘永明,等.当归抗家兔主动脉粥样硬化形成的作用[J].中国动脉硬化杂志,2000,8(1)：46-48
[14]廖维靖,田峻,杨万同.当归注射液延缓坐骨神经损伤后肌肉萎缩的研究[J].中成药,1997,19(4)：26.
[15]杨万同,廖维靖,刘玲俐,等.中药当归对大鼠坐骨神经损伤后髓鞘再生的形态研究[J].湖北医科大学学报,1998,19(4)：343.
[16]冯景奇,柳钟勋,左增艳,等.当归多糖及当归内酯对小鼠细胞免疫功能的影响[J].中国免疫学杂志,1998,14(4)：279-281
[17]冯景奇,柳钟勋.当归内酯拮抗环抱菌素A、氢化可的松及抗肿瘤药物的免疫抑制作用[J].中国免疫学杂志,2000,16(1)：22-24
[18]王秀云.枸杞多糖的药理学研究发展[J].医学创新研究,2007,7(4)：27-28
[1]胡有谷.腰椎间盘突出症[M].第二版，北京,人民卫生出版社,1995,248
[2]姚新苗.腰椎间盘突出症中医治疗[M].上海科学技术出版杜,2002,64-70
[3]熊晓芊,邵增务,杨述华.聚集蛋白聚糖与椎间盘退变的研究进展[J].中国脊柱脊髓杂志,2005,15(1)：55.
[4]赵长青,王利民.凋亡与椎间盘退变[J].华北煤炭医学院学报,2005,7(2)：169.
[5]李小川,李雷.Fas/FasL基因在退变腰椎间盘组织中的表达及诱导凋亡作用[J].中华医学杂志,2005,25(24):1718.
[6]刘海心,王德春,胡有谷.椎间盘的营养与退变[J].中国矫形外科杂志,2006,14(1)：863.
[7]范小良,范顺武,秦安.锥体终板与椎间盘退变[J].国际骨科杂志，2006,7(27)：246.
[8]李卫国,邱勇,王斌.脊柱节段血管阻断对椎间盘退变发生发展的影响[J].中国脊柱脊髓杂志,2004,14(6)：348.
[9]王守丰,邱勇.生物力学因素对椎体生长板的影响和临床意义[J].中国脊柱脊髓杂志,2006,16(4)：301.
[10]Thomp son RE, PearcyMJ, Downing KJ et al. Disc lesions and the me2chanics of the intervertebral joint comp lex [J]. Sp ine,2000,25(23): 3026.
[11]Meakin JR, HukinsDW. Effect of removing the nucleus pulposus on the deformation of theannulus fibrosus during comp ression of the interverte bral dis[J]. J Biomech,2000,33 (5):575.
[12]熊敏,张建众,徐吉.腰椎间盘突出病程中腰椎生理弧度僵直的生物力学改变[J].中国临床康复,2003,7(6)：933.
[13]柳根哲,徐林.椎间盘退变生物力学的研究现状[J].中国矫形外科杂志,2005,13(11)：856.
[14]周则美.免疫球蛋白IgG及IgM含量与腰椎间盘突出症病理分型的相关性 [J].中国临床康复,2003,7(14)：2040.
[15]Sp iliopoulou I, Korovessis P, Konstantinou D, et al. lgG and lgM concen2 tration in the p rolap sed human intervertebral disc and sciatica etiology [J]. Sp ine,1994,19:1320.
[16]Wehling P, Cleveland SJ. Neurophysiologic changes in lumber nerve root inflammation in the rat after treatment with cytokin inhibitors[J].Sp ine,1996,21:931.
[17]Kobayashi, Shigeru Baba, Hisatoshi. Effect ofMechanical Compression on the LumbarNerve Root:Localization and Changes of Intraradicular Inflammatory Cytokines, Nitric Oxide, and Cyclooxygenase[J]. Sp ine,2005,30 (15):1699.
[18]Betz P, Nerlich A, Wilske J, et al. Time dependent pericelluar exp res2 sion of collagen type IV laminin and heparan sulfate p roteglycan inmyo2 fibroblasts[J]. Int LegalMed,1992,105:169.
[19]王湘达,陈伯华.Ⅳ型胶原在退变椎间盘中的表达及意义[J].青岛大学医学院学报,2003,39(3)：318.
[20]魏见伟,王德春,胡有谷.基质金属蛋白酶及其抑制因子与腰椎间盘退变关系的研究进展[J].中国脊柱脊髓杂志,2006,16(4)：304.
[21]Goup ille H, JaysonM, Valat J, et al. Matrix metallop roteinases:the clueto intervertebral disc degeneration [J]. Sp ine,1998,23:1612.
[22]KanemotoM, Hukuda S, Komiya Y, etal. Immunohisto chemical study of matrixmetallop roteinase and tissue inhibitor ofmetallop roteinase in hu2 man intervertebral discs[J]. Sp ine,1996,21:1.
[23]Crean JK, Robert S, Jaffary Dc, et al. Matrix metallop roteinases in the human intenrertebral disc:role in disc degeneration and scoliosis. Sp ine,1997,22:2877.
[24]Hatano, Eiju, Fujita, Takuya, Exp ression ofADAMTS-4 (aggrecanase-1) and Possible Involvement in Regression of Lumbar Disc Hernia2 tion[J]. sp ine,2006,31 (13): 1426.
[25]DoitaM, Kanatani T, Ozaki T, et al. Influence of macrop roteinases: the clue to intervertebral disc, degeneration [J]. Sp ine,1998,14:1612. [26] Gronblad M. Sp inal disorders:basic science [J]. Actaorthop Scand Supp 1.1998,281:32
[27]田庆显,胡有谷,郑洪军等.白细胞介素-1对椎间盘蛋白多糖代谢的影响[J].中华骨科杂志,2000,20(4)：242.
[28]Takahashi, Naoto, Kikuchi, TNF-a and Phosphorylation of ERK in DRG and Sp inal Cord:Insight, s Into Mechanisms of Sciatica [J]. spine, 2006,31 (5):523.
[29]胡绪江，邵增务.外源性肿瘤坏死因子-α对腰椎间盘退变影响的实验研究[J].中国脊柱脊髓杂志,2006,16(7)：541.
[30]Valdes, Ana M, Hassett, Geraldine MBBS. Radiographic Progression of Lumbar Sp ine Disc Degeneration Is Influenced by Variation at Inflam2 matory Genes:A Candidate SNP Association Study in the Chingford Co2 hort[J]. sp ine,2005,30 (21):2445.
[31]Kawaguchi S, Yamashita T, Katahira G, et al, Sp ine,2002,27(14): 1511.
[32]赵太茂,刘森,宋红星,等.突出椎间盘组织中TNF-a与IL-b的表达及意义[J].中国脊柱脊髓杂志,1999,9(1)：17.
[33]龙厚清,李佛保.腰椎间盘中转化生长因子B1的合成和基因表达[J].脊柱外科杂志,2004,2(2)：84.
[34]彭宝淦,姜笃银.椎间盘退变过程中碱性成纤维细胞生长因子和转移生长因子的表达及其意义[J].中国脊柱脊髓杂志,2005,15(6)：353.
[35]陈飞.突出腰椎间盘组织VEGF的表达及其意义[J].中国医师杂志,2005,7(10)：1314.
[36]叶君健,宋继红.腰椎间盘突出髓核组织磷脂酶A2表达的临床研究[J].中国骨与关节损伤杂志,2006,21(4)：259.
[37]胡宝山,丁悦.纤维粘连蛋白EDA+片段在椎间盘中的表达及意义[J].中 国矫形外科杂志，2006，14(5)：371.
[38]Brisby H, Byrod G. Olmarker K et alNitricoxide as a mediator of nucle2 us pulposus-inducedefects on sp inal nerve roots [J]. J Orthop Res,2000, 18 (5):81.
[39]Kang JD, Stefanovic RacicM, M c Intyre LA. Toward abiochemical un2 derstanding of human intervertebral discdegeneration and herniation: Contribution of nitricoxide, interleukins, p rostaglandin E2, and, matrix metallop roteinases[J]. Spine,1997,22 (10):1065.
[40]Bush K, Cowen N, Katz D, et al.The nature history of saiatic associated with disc pathology:aprospective study with clinical and independernt radiologic follow-up. Spine,1992,17:1205-1212
[41]贾经汉.中西医结合诊治腰椎间盘突出症1586例回顾分析[J],中国临床康复,2006,10(39),24-6
[42]关平,柳光元,冯哲贤.骨盆牵引治疗腰椎间盘突出症32例[J].右江民族医学院学报,1997 19(12)：52-53
[43]Onel D, Tuzlaci M, Sari H, et al. Computed tomographic investigation of effect of traction on lumbar disc herniation. Spine,1989,14:1
[44)王俊,王淑华,黄金莲.牵引推拿治疗腰椎间盘突出症的机理研究进展[J].云南中医中药杂志,2004,25(1)：41-43
[45]朱换平,宋敏,谢兴文,等.手法治疗腰椎间盘突出症的研究现状[J].中医研究,、2002,15(5)：54-57
[46]王福根,高谦,毕胜,等.腰椎间盘突出症临床治疗机制探讨[J].中国临床康复,2003,7(8)：1320
[47]李元明.身痛逐瘀汤加减治疗腰椎间盘突出症[J].中国中医骨科,2001,9(4)：34-401
[48]张雪飞.王昭佩教授治疗腰椎间盘突出症临床经验[J].现代中医药.2005.25(6)：2
[49]朴钟源,尹继勇,田亮.从肝论治腰椎间盘突出症38例.实用中医内科杂志[J].2003：17(6)：105
[50]刘向前.姚共和教授诊疗腰椎间盘突出症学术经验介绍[J].湖南中医学院学报.2003,23(3)：25-26
[51]李浩钢.石仰山治伤从痰论治[J].上海中医药杂志.2000.3：34-35
[52]沈杰枫.周福贻治疗腰椎间盘突出症的经验[J].江苏中医1999.20(3)：10-11
[53]候莉娟.中药治疗腰椎间盘突出症机理研究进展[J].中国中医骨伤科杂志2007.15(3)：71-72
[54]鲍杰,韦坚,韦贵康.中药热熨治疗血瘀型腰椎间盘突出症疗效观察及对其血液流变学的影响[J].中医正骨,2002,1(411)：7
[55]沈钦荣，杨金团,刘奕锋,等.灵仙痛消散热熨治疗腰椎间盘突出症临床观察[J].中医正骨,2002,1(42)：18.
[56]王华兰.推拿配合中药外敷治疗腰腿痛102例临床观察[J].按摩与导引,2001，1(72)：50.
[57]刘志群,张广清,岑少兰.中药熏蒸加牵引治疗急性腰椎间盘突出症[J].中医正骨,2002,1(42)：42.
[58]周洁.针刺治疗腰椎间盘突出症40例报告[J].中医正骨,1997,9(3)：42
[59].谢松林.温针夹脊穴为主治疗腰椎间盘突出症100例[J].陕西中医,2006,27(5)：599-600
[60]王升旭,李树成,老锦雄.电针夹脊穴治疗腰椎间盘突出症的临床观察及机理探讨[J].中国针灸.2000,20(3)：166-168
[61]潘海根,刘霞,袁浩明.穴位注射甲钴胺在腰椎间盘突出症中的应用[J]中国针灸,2003,23(4)：210
[62]乐旭华,傅莉萍.穴位注射为主治疗腰椎间盘突出症56例[J].上海针灸杂志,2002,21(4)：36
[63]孙治东,王娟娟.穴位贴敷治疗腰椎间盘突出症40例疗效观察[J].中国针灸,1998,18(2)：107-108
[64]刘幸娟.腕踝针治疗腰椎间盘突出症57例[J].湖北中医志,1999,21(11)：523
[65]李义凯，王爱华,张志凌.腰痛的药物治疗(国外文献综述)[J].颈腰痛杂志,2000,21(1)：70-73
[66]王钢,刘保.注射用p一七叶皂贰钠治疗急重型腰椎间盘突出症疗效观察[J].甘肃中医学院学报,2000,12,17(4)：13-14
[67]李越,杨光毅,王宏.腰椎间盘突出症的手术治疗[J].华西医学，,2005；20(4>：732-733
[68]李五洲,张记恩.腰椎间盘突出症的手术治疗进展[J].湖北省卫生职工医学院学报,2004：9(17)：90-91
[2]国家中医药管理局.中医病证诊断疗效标准[M].南京：南京大学出版社,1994：193
[3]汪沪双.乌头碱抗风湿作用的药效学研究概述[J].基层中药杂志,1996,10(3)：45-46.
[4]董万超.肉桂的利用及药理作用[J]特种经济动植物,2005,6：43
[5]聂淑琴,梁爱华.鹿角胶新老剂型壮阳、补血作用的比较研究[J].中国中药杂志,1996,21(10)：625.
[6]王龙,张晓华.六种补胶的比较研究[J].中国中药杂志,1992,17(1)：19.
[7]吕晓东,张永祥,茹祥斌,山茱萸体液免疫抑制活性成分的药理学导向评价分离[J]解放军药学学报,2002,18(6)：357-359
[8]刘栋魏睦新：健脾补肾活血方延缓衰老的实验研究[J].河南中医,2000,20(4)：25-26
[9]徐增莱.淮山药多糖的免疫调节作用研究[J].时珍国医国药2007,18(5)：5-6
[10]Kim SS, Son YO, Chun JC, et al. Antioxidant property of an active component purified from the leaves of paraquat-tolerant Rehmannia glutinosa. Redox Rep,2005,10(6):311-318.
[11]赖娟华,徐丽瑛,饶华.等.杜仲叶化学成分和药理作用研究概况[J].实用中西医结合临床,2004,4(2)：67.
[12]王浴生.中药药理与应用[M].北京：人民卫生出版社,1983年,第1版
[13]余追,欧阳静萍,刘永明,等.当归抗家兔主动脉粥样硬化形成的作用[J].中国动脉硬化杂志,2000,8(1)：46-48
[14]廖维靖,田峻,杨万同.当归注射液延缓坐骨神经损伤后肌肉萎缩的研究[J].中成药,1997,19(4)：26.
[15]杨万同,廖维靖,刘玲俐,等.中药当归对大鼠坐骨神经损伤后髓鞘再生的形态研究[J].湖北医科大学学报,1998,19(4)：343.
[16]冯景奇,柳钟勋,左增艳,等.当归多糖及当归内酯对小鼠细胞免疫功能的影响[J].中国免疫学杂志,1998,14(4)：279-281
[17]冯景奇,柳钟勋.当归内酯拮抗环抱菌素A、氢化可的松及抗肿瘤药物的免疫抑制作用[J].中国免疫学杂志,2000,16(1)：22-24
[18]王秀云.枸杞多糖的药理学研究发展[J].医学创新研究,2007,7(4)：27-28
[1]胡有谷.腰椎间盘突出症[M].第二版，北京,人民卫生出版社,1995,248
[2]姚新苗.腰椎间盘突出症中医治疗[M].上海科学技术出版杜,2002,64-70
[3]熊晓芊,邵增务,杨述华.聚集蛋白聚糖与椎间盘退变的研究进展[J].中国脊柱脊髓杂志,2005,15(1)：55.
[4]赵长青,王利民.凋亡与椎间盘退变[J].华北煤炭医学院学报,2005,7(2)：169.
[5]李小川,李雷.Fas/FasL基因在退变腰椎间盘组织中的表达及诱导凋亡作用[J].中华医学杂志,2005,25(24):1718.
[6]刘海心,王德春,胡有谷.椎间盘的营养与退变[J].中国矫形外科杂志,2006,14(1)：863.
[7]范小良,范顺武,秦安.锥体终板与椎间盘退变[J].国际骨科杂志，2006,7(27)：246.
[8]李卫国,邱勇,王斌.脊柱节段血管阻断对椎间盘退变发生发展的影响[J].中国脊柱脊髓杂志,2004,14(6)：348.
[9]王守丰,邱勇.生物力学因素对椎体生长板的影响和临床意义[J].中国脊柱脊髓杂志,2006,16(4)：301.
[10]Thomp son RE, PearcyMJ, Downing KJ et al. Disc lesions and the me2chanics of the intervertebral joint comp lex [J]. Sp ine,2000,25(23): 3026.
[11]Meakin JR, HukinsDW. Effect of removing the nucleus pulposus on the deformation of theannulus fibrosus during comp ression of the interverte bral dis[J]. J Biomech,2000,33 (5):575.
[12]熊敏,张建众,徐吉.腰椎间盘突出病程中腰椎生理弧度僵直的生物力学改变[J].中国临床康复,2003,7(6)：933.
[13]柳根哲,徐林.椎间盘退变生物力学的研究现状[J].中国矫形外科杂志,2005,13(11)：856.
[14]周则美.免疫球蛋白IgG及IgM含量与腰椎间盘突出症病理分型的相关性 [J].中国临床康复,2003,7(14)：2040.
[15]Sp iliopoulou I, Korovessis P, Konstantinou D, et al. lgG and lgM concen2 tration in the p rolap sed human intervertebral disc and sciatica etiology [J]. Sp ine,1994,19:1320.
[16]Wehling P, Cleveland SJ. Neurophysiologic changes in lumber nerve root inflammation in the rat after treatment with cytokin inhibitors[J].Sp ine,1996,21:931.
[17]Kobayashi, Shigeru Baba, Hisatoshi. Effect ofMechanical Compression on the LumbarNerve Root:Localization and Changes of Intraradicular Inflammatory Cytokines, Nitric Oxide, and Cyclooxygenase[J]. Sp ine,2005,30 (15):1699.
[18]Betz P, Nerlich A, Wilske J, et al. Time dependent pericelluar exp res2 sion of collagen type IV laminin and heparan sulfate p roteglycan inmyo2 fibroblasts[J]. Int LegalMed,1992,105:169.
[19]王湘达,陈伯华.Ⅳ型胶原在退变椎间盘中的表达及意义[J].青岛大学医学院学报,2003,39(3)：318.
[20]魏见伟,王德春,胡有谷.基质金属蛋白酶及其抑制因子与腰椎间盘退变关系的研究进展[J].中国脊柱脊髓杂志,2006,16(4)：304.
[21]Goup ille H, JaysonM, Valat J, et al. Matrix metallop roteinases:the clueto intervertebral disc degeneration [J]. Sp ine,1998,23:1612.
[22]KanemotoM, Hukuda S, Komiya Y, etal. Immunohisto chemical study of matrixmetallop roteinase and tissue inhibitor ofmetallop roteinase in hu2 man intervertebral discs[J]. Sp ine,1996,21:1.
[23]Crean JK, Robert S, Jaffary Dc, et al. Matrix metallop roteinases in the human intenrertebral disc:role in disc degeneration and scoliosis. Sp ine,1997,22:2877.
[24]Hatano, Eiju, Fujita, Takuya, Exp ression ofADAMTS-4 (aggrecanase-1) and Possible Involvement in Regression of Lumbar Disc Hernia2 tion[J]. sp ine,2006,31 (13): 1426.
[25]DoitaM, Kanatani T, Ozaki T, et al. Influence of macrop roteinases: the clue to intervertebral disc, degeneration [J]. Sp ine,1998,14:1612. [26] Gronblad M. Sp inal disorders:basic science [J]. Actaorthop Scand Supp 1.1998,281:32
[27]田庆显,胡有谷,郑洪军等.白细胞介素-1对椎间盘蛋白多糖代谢的影响[J].中华骨科杂志,2000,20(4)：242.
[28]Takahashi, Naoto, Kikuchi, TNF-a and Phosphorylation of ERK in DRG and Sp inal Cord:Insight, s Into Mechanisms of Sciatica [J]. spine, 2006,31 (5):523.
[29]胡绪江，邵增务.外源性肿瘤坏死因子-α对腰椎间盘退变影响的实验研究[J].中国脊柱脊髓杂志,2006,16(7)：541.
[30]Valdes, Ana M, Hassett, Geraldine MBBS. Radiographic Progression of Lumbar Sp ine Disc Degeneration Is Influenced by Variation at Inflam2 matory Genes:A Candidate SNP Association Study in the Chingford Co2 hort[J]. sp ine,2005,30 (21):2445.
[31]Kawaguchi S, Yamashita T, Katahira G, et al, Sp ine,2002,27(14): 1511.
[32]赵太茂,刘森,宋红星,等.突出椎间盘组织中TNF-a与IL-b的表达及意义[J].中国脊柱脊髓杂志,1999,9(1)：17.
[33]龙厚清,李佛保.腰椎间盘中转化生长因子B1的合成和基因表达[J].脊柱外科杂志,2004,2(2)：84.
[34]彭宝淦,姜笃银.椎间盘退变过程中碱性成纤维细胞生长因子和转移生长因子的表达及其意义[J].中国脊柱脊髓杂志,2005,15(6)：353.
[35]陈飞.突出腰椎间盘组织VEGF的表达及其意义[J].中国医师杂志,2005,7(10)：1314.
[36]叶君健,宋继红.腰椎间盘突出髓核组织磷脂酶A2表达的临床研究[J].中国骨与关节损伤杂志,2006,21(4)：259.
[37]胡宝山,丁悦.纤维粘连蛋白EDA+片段在椎间盘中的表达及意义[J].中 国矫形外科杂志，2006，14(5)：371.
[38]Brisby H, Byrod G. Olmarker K et alNitricoxide as a mediator of nucle2 us pulposus-inducedefects on sp inal nerve roots [J]. J Orthop Res,2000, 18 (5):81.
[39]Kang JD, Stefanovic RacicM, M c Intyre LA. Toward abiochemical un2 derstanding of human intervertebral discdegeneration and herniation: Contribution of nitricoxide, interleukins, p rostaglandin E2, and, matrix metallop roteinases[J]. Spine,1997,22 (10):1065.
[40]Bush K, Cowen N, Katz D, et al.The nature history of saiatic associated with disc pathology:aprospective study with clinical and independernt radiologic follow-up. Spine,1992,17:1205-1212
[41]贾经汉.中西医结合诊治腰椎间盘突出症1586例回顾分析[J],中国临床康复,2006,10(39),24-6
[42]关平,柳光元,冯哲贤.骨盆牵引治疗腰椎间盘突出症32例[J].右江民族医学院学报,1997 19(12)：52-53
[43]Onel D, Tuzlaci M, Sari H, et al. Computed tomographic investigation of effect of traction on lumbar disc herniation. Spine,1989,14:1
[44)王俊,王淑华,黄金莲.牵引推拿治疗腰椎间盘突出症的机理研究进展[J].云南中医中药杂志,2004,25(1)：41-43
[45]朱换平,宋敏,谢兴文,等.手法治疗腰椎间盘突出症的研究现状[J].中医研究,、2002,15(5)：54-57
[46]王福根,高谦,毕胜,等.腰椎间盘突出症临床治疗机制探讨[J].中国临床康复,2003,7(8)：1320
[47]李元明.身痛逐瘀汤加减治疗腰椎间盘突出症[J].中国中医骨科,2001,9(4)：34-401
[48]张雪飞.王昭佩教授治疗腰椎间盘突出症临床经验[J].现代中医药.2005.25(6)：2
[49]朴钟源,尹继勇,田亮.从肝论治腰椎间盘突出症38例.实用中医内科杂志[J].2003：17(6)：105
[50]刘向前.姚共和教授诊疗腰椎间盘突出症学术经验介绍[J].湖南中医学院学报.2003,23(3)：25-26
[51]李浩钢.石仰山治伤从痰论治[J].上海中医药杂志.2000.3：34-35
[52]沈杰枫.周福贻治疗腰椎间盘突出症的经验[J].江苏中医1999.20(3)：10-11
[53]候莉娟.中药治疗腰椎间盘突出症机理研究进展[J].中国中医骨伤科杂志2007.15(3)：71-72
[54]鲍杰,韦坚,韦贵康.中药热熨治疗血瘀型腰椎间盘突出症疗效观察及对其血液流变学的影响[J].中医正骨,2002,1(411)：7
[55]沈钦荣，杨金团,刘奕锋,等.灵仙痛消散热熨治疗腰椎间盘突出症临床观察[J].中医正骨,2002,1(42)：18.
[56]王华兰.推拿配合中药外敷治疗腰腿痛102例临床观察[J].按摩与导引,2001，1(72)：50.
[57]刘志群,张广清,岑少兰.中药熏蒸加牵引治疗急性腰椎间盘突出症[J].中医正骨,2002,1(42)：42.
[58]周洁.针刺治疗腰椎间盘突出症40例报告[J].中医正骨,1997,9(3)：42
[59].谢松林.温针夹脊穴为主治疗腰椎间盘突出症100例[J].陕西中医,2006,27(5)：599-600
[60]王升旭,李树成,老锦雄.电针夹脊穴治疗腰椎间盘突出症的临床观察及机理探讨[J].中国针灸.2000,20(3)：166-168
[61]潘海根,刘霞,袁浩明.穴位注射甲钴胺在腰椎间盘突出症中的应用[J]中国针灸,2003,23(4)：210
[62]乐旭华,傅莉萍.穴位注射为主治疗腰椎间盘突出症56例[J].上海针灸杂志,2002,21(4)：36
[63]孙治东,王娟娟.穴位贴敷治疗腰椎间盘突出症40例疗效观察[J].中国针灸,1998,18(2)：107-108
[64]刘幸娟.腕踝针治疗腰椎间盘突出症57例[J].湖北中医志,1999,21(11)：523
[65]李义凯，王爱华,张志凌.腰痛的药物治疗(国外文献综述)[J].颈腰痛杂志,2000,21(1)：70-73
[66]王钢,刘保.注射用p一七叶皂贰钠治疗急重型腰椎间盘突出症疗效观察[J].甘肃中医学院学报,2000,12,17(4)：13-14
[67]李越,杨光毅,王宏.腰椎间盘突出症的手术治疗[J].华西医学，,2005；20(4>：732-733
[68]李五洲,张记恩.腰椎间盘突出症的手术治疗进展[J].湖北省卫生职工医学院学报,2004：9(17)：90-91